Heghine Khachatryan: Intracranial Hemorrhage in Leukemia – Beyond Thrombocytopenia
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared RPTH Journal’s post on LinkedIn:
“Intracranial hemorrhage in leukemia – beyond thrombocytopenia
Emerging pathology data highlight a critical mechanism: leukemic cell infiltration of cerebral vessels leading to direct vascular injury.
Key mediators such as cathepsin G and VEGF appear to drive endothelial damage, meningeal invasion, and ultimately bleeding.
Takeaway:
Intracranial hemorrhage in leukemia is not purely a coagulation defect – it is also a vascular disease driven by leukemic biology.”
RPTH Journal shared a post on LinkedIn about a recent article by Toshihiro Gi et al., published in RPTH Journal, adding:
“Intracranial hemorrhage in leukemia: what do autopsy findings reveal about the underlying mechanisms?
Intracranial haemorrhage (ICH) is one of the most devastating complications of leukemia, yet the mechanisms driving cerebral vascular injury and CNS involvement remain poorly understood.
A new autopsy-based study in RPTH Journal sheds light on this critical question.
Key findings from 37 leukemia cases and 20 matched controls:
- ICH was identified in 68% of leukemia cases, with fatal brain herniation in 40%
- CNS involvement was observed in 54% of cases, often without a prior clinical diagnosis
- Leukemic cell infiltration of meninges and vascular walls was frequently associated with structural changes in smooth muscle cells and adventitial collagen
- VEGF was highly expressed in leukemia cells and linked to meningeal invasion
- Cathepsin G, predominantly expressed in myeloid leukemia, was associated with cerebral vascular damage
The identification of VEGF and cathepsin G as potential markers of CNS invasion and vascular injury opens promising avenues for earlier detection and targeted intervention in leukemia-associated ICH.”
Title: Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage
Authors: Toshihiro Gi, Kaiyou Kai, Kotaro Shide, Eriko Nakamura, Nobuyuki Oguri, Murasaki Aman, Kazunari Maekawa, Sayaka Moriguchi-Goto, Michikazu Nakai, Kazuya Shimoda, Yohei Hisada, Atsushi Yamashita
Other posts featuring Heghine Khachatryan and RPTH Journal on Hemostasis Today.
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters
-
Oct 28, 2026, 13:13Michael Cahillane: Three-Buffy-Coat Platelets – Strengthening Blood Supply Resilience
-
Oct 28, 2026, 13:05N. Mariana S. Vasquez: Antiplatelets vs Anticoagulants – Key Clinical Differences
-
Oct 28, 2026, 12:45Panithaya Chareonthaitawee: A Podcast Walk Through Anticoagulation
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score
-
Oct 28, 2026, 08:40Simon Fletcher: The Hidden Burden of Non-Severe Haemophilia
-
Oct 28, 2026, 08:08Paul Agwu: A Low Platelet Count Is Not a Diagnosis – It Is a Clue
-
Oct 28, 2026, 07:54Ifeanyichukwu Ifechidere: When Normal Results Don’t Explain the Bleeding
-
Oct 28, 2026, 06:06Thirunavukkarasu Angappan: Anti-TFPI Antibodies and an Antithrombin-Lowering Drug